Deconvoluting complex tissues for expression quantitative trait locus-based analyse

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1620, 2013, Pages

  Seo, Ji Heui ^a   Li, Qiyuan ^a,c,d   Fatima, Aquila ^b   Eklund, Aron ^d   Szallasi, Zoltan ^d,e,f   Polyak, Kornelia ^a,f   Richardson, Andrea L ^b,f,g   Freedman, Matthew L ^a,c,f  

^a The Center for Functional Cancer Epigenetics   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer risk single nucleotide polymorphisms; Expression quantitative trait locus; Heterogeneous tissue

Indexed keywords

CANCER; GENE EXPRESSION; HEALTH RISK; PATHOGENICITY; PROTEIN; QUANTITATIVE ANALYSIS;

GENETIC MARKER; TRANSCRIPTOME;

ADIPOCYTE; BIOLOGY; BREAST; BREAST RECONSTRUCTION; BREAST TUMOR; CYTOLOGY; EPITHELIUM; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETICS; HUMAN; METABOLISM; PREDICTIVE VALUE; PROCEDURES; QUANTITATIVE TRAIT LOCUS; RISK FACTOR;

ADIPOCYTES; BREAST; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; EPITHELIUM; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC MARKERS; HUMANS; MAMMAPLASTY; PREDICTIVE VALUE OF TESTS; QUANTITATIVE TRAIT LOCI; RISK FACTORS; TRANSCRIPTOME;

EID: 84891472019     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0363     Document Type: Article

References (28)

1. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, Manolio TA. 2013 A catalog of published genome-wide association studies. http://www.genome.gov/gwastudies accessed 25 January 2013.
2. Maurano MT et al. 2012 Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195.doi:10.1126/science.1222794
3. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. 2010 Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888.doi:10.1371/journal.pgen.1000888
4. Grisanzio C et al. 2012 Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc. Natl Acad. Sci. USA 109, 11 252-611+257.doi:10.1073/pnas.1200853109
5. Small KS et al. 2011 Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet. 43, 561-564.doi:10.1038/ng.833
6. Pomerantz MM et al. 2010 Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 6, e1001204.doi:10.1371/journal.pgen.1001204
7. Musunuru K et al. 2010 From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714-719.doi:10.1038/nature09266
8. Chen Y et al. 2008 Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435.doi:10.1038/nature06757
9. Emilsson V et al. 2008 Genetics of gene expression and its effect on disease. Nature 452, 423-428.doi:10.1038/nature06758
10. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML. 2013 Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633-641.doi:10.1016/j.cell.2012.12.034
11. Loo LW et al. 2012 cis-Expression QTL analysis of established colorectal cancer risk variants in colon tumors and adjacent normal tissue. PLoS ONE 7, e30477.doi:10.1371/journal.pone.0030477
12. Dobrin R, Greenawalt DM, Hu G, Kemp DM, Kaplan LM, Schadt EE, Emilsson V. 2011 Dissecting cis regulation of gene expression in human metabolic tissues. PLoS ONE 6, e23480.doi:10.1371/journal. pone.0023480
13. Wu ZJ et al. 2010 Gene expression profiling of human breast tissue samples using SAGE-Seq. Genome Res. 20, 1730-1739.doi:10.1101/gr. 108217.110
14. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. 2009 Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184-194.doi:10.1038/nrg2537
15. Lu P, Nakorchevskiy A, Marcotte EM. 2003 Expression deconvolution: a reinterpretation of DNA microarray data reveals dynamic changes in cell populations. Proc. Natl Acad. Sci. USA 100, 10 370-310+375.doi:10.1073/pnas.0134757100
16. Venet D, Pecasse F, Maenhaut C, Bersini H. 2001 Separation of samples into their constituents using gene expression data. Bioinformatics 17Suppl. 1, S279-S287.doi:10.1093/bioinformatics/17. suppl_1.S279
17. Shen-Orr SS et al. 2010 Cell type-specific gene expression differences in complex tissues. Nat. Methods 7, 287-289.doi:10.1038/nmeth.1439
18. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BA. 2008 Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol. 6, e108.doi:10.1371/journal.pbio.0060108
19. Huijts PE et al. 2011 Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Breast Cancer Res. 13, R72.doi:10.1186/bcr2917
20. Sun C, Olopade OI, Di Rienzo A. 2010 rs2981582 is associated with FGFR2 expression in normal breast. Cancer Genet. Cytogenet. 197, 193-194.doi:101016/j.cancergencyto.2009.11.006
21. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ. 2006 The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 66, 5330-5337.doi:10.1158/0008-5472.CAN-06-0037
22. Berteaux N et al. 2005 H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem. 280, 29 625-629+636.doi:10.1074/jbc.M504033200
23. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ. 2002 Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 23, 1885-1895.doi:10.1093/carcin/23.11.1885
24. Garg P, Borel C, Sharp AJ. 2012 Detection of parentof- origin specific expression quantitative trait loci by cis-association analysis of gene expression in trios. PLoS ONE 7, e41695.doi:10.1371/journal. pone.0041695
25. Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N. 2001 Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase AKR1C3. Mol. Cell. Endocrinol. 171, 137-149.doi:10.1016/S0303-72070000426-3
26. Lewis MJ, Wiebe JP, Heathcote JG. 2004 Expression of progesterone metabolizing enzyme genes AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2 is altered in human breast carcinoma. BMC Cancer 4, 27.doi:10.1186/1471-2407-4-27
27. Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, Stanczyk FZ, Stolz A. 2004 Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 64, 7610-7617.doi:10.1158/0008-5472.CAN-04-1608
28. Wang Y et al. 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.doi:10.1016/S0140-67360517947-1